Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Q3 2024 Earnings Call Transcript November 6, 2024
Praxis Precision Medicines, Inc. beats earnings expectations. Reported EPS is $-0.00275, expectations were $-1.99.
Operator: Good day and thank you for standing by. Welcome to the Praxis Precision Medicines Third Quarter 2024 Corporate Update. At this time, all participants are in a listen-only mode. Please be advised that today’s conference is being recorded. After the speakers’ presentation,...
